Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Abdominal Ultrasound – The Leading Method in Duodenal Gist Diagnostics (CROSBI ID 308424)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Bohnec, Sven ; Budimir, Ivan ; Hrabar, Davor ; Babić, Nenad ; Budimir, Ivan Jr ; Nikolić, Marko ; Pavić ; Ivana Abdominal Ultrasound – The Leading Method in Duodenal Gist Diagnostics // Acta clinica Croatica, 56 (2017), 1; 183-187. doi: 10.20471/acc.2017.56.01.26

Podaci o odgovornosti

Bohnec, Sven ; Budimir, Ivan ; Hrabar, Davor ; Babić, Nenad ; Budimir, Ivan Jr ; Nikolić, Marko ; Pavić ; Ivana

engleski

Abdominal Ultrasound – The Leading Method in Duodenal Gist Diagnostics

Gastrointestinal stromal tumors (GIST) are the most common mesenchymal tumors of the digestive tract and are generally asymptomatic. A 39- year- old female patient was hospitalized in 2012 at Clinical Department of Internal Medicine, Sestre milosrdnice University Hospital Center, for a focal hypodense irregular circular lesion located in segment III of the left hepatic lobe, accidentally found by ultrasonography and verified by computed tomography. The findings were also verified with nuclear magnetic resonance and esophagogastroduodenoscopy. A biopsy sample of the lesion was analyzed by histologic and immunohistochemical methods and identified as GIST. The patient underwent surgical operation (tumor excision with terminoterminal anastomosis created between the second segment of duodenum and jejunum and resection of liver segment III). The histopathologic findings matched GIST with a high probability of relapse according to the localization, size, mitotic activity and Ki-67 values. Therefore, therapy with imatinib at a dose of 400 mg/day was administered. Three years after the operation, the patient is still in remission.

gastrointestinal stromal tumors – diagnostic imaging ; ultrasonography ; elasticity imaging techniques ; imatinib mesylate ; case reports

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

56 (1)

2017.

183-187

objavljeno

0353-9466

1333-9451

10.20471/acc.2017.56.01.26

Povezanost rada

Kliničke medicinske znanosti

Poveznice